We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
301
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$2.79K ﹤0.01%
+94
New +$2.67K
ADCT icon
302
ADC Therapeutics
ADCT
$139M
– –
-5,701,655
Closed -$21.4M
AMT icon
303
American Tower
AMT
$82.8B
– –
-13,793
Closed -$2.35M
AUR icon
304
Aurora
AUR
$12.9B
– –
-36,899
Closed -$143K
AVB
305
DELISTED
AvalonBay Communities
AVB
– –
-2,346
Closed -$379K
AVPT icon
306
AvePoint
AVPT
$2.88B
– –
-15,133
Closed -$142K
CNTA
307
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-668,142
Closed -$26.5M
COMP icon
308
Compass
COMP
$7.95B
– –
-10,956
Closed -$75K
CRVS icon
309
Corvus Pharmaceuticals
CRVS
$1.09B
– –
-550,000
Closed -$8.05M
CSTL icon
310
Castle Biosciences
CSTL
$1.08B
– –
-386,425
Closed -$9.49M
CTMX icon
311
CytomX Therapeutics
CTMX
$586M
– –
-900,000
Closed -$4.23M
HELP
312
Cybin Inc
HELP
$959M
– –
-1,410,815
Closed -$6.77M
DLR icon
313
Digital Realty Trust
DLR
$66.5B
– –
-1,691
Closed -$296K
DOCU
314
DocuSign
DOCU
$13.4B
– –
-8,589
Closed -$406K
DT icon
315
Dynatrace
DT
$15.9B
– –
-7,872
Closed -$292K
VMRK
316
Vivmark Residential
VMRK
$50.8B
– –
-9,436
Closed -$553K
EQT icon
317
EQT Corp
EQT
$33.2B
– –
-399,975
Closed -$25.5M
EVH icon
318
Evolent Health
EVH
$423M
– –
-2,547,558
Closed -$5.81M
EWTX icon
319
Edgewise Therapeutics
EWTX
$4.74B
– –
-149,863
Closed -$4.72M
FROG icon
320
JFrog
FROG
$11.7B
– –
-16,720
Closed -$785K
GEN icon
321
Gen Digital
GEN
$18.7B
– –
-34,584
Closed -$634K
GLBE icon
322
Global E Online
GLBE
$6.13B
– –
-1,218,345
Closed -$37.6M
HDB icon
323
HDFC Bank
HDB
$116B
– –
-8,633
Closed -$208K
IVVD icon
324
Invivyd
IVVD
$245M
– –
-9,071,995
Closed -$11.8M
MANH icon
325
Manhattan Associates
MANH
$12.2B
– –
-2,007
Closed -$262K
10 11 12
13
14

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.